iSTAR Medical Expands International Commercial Rollout of MINIject® with Successful First Implants Completed in Australia
January 10, 2024 03:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical Expands International Commercial Rollout of MINIject® with Successful First Implants Completed in Australia WAVRE, Belgium — 10 January 2024: iSTAR Medical, a...
iSTAR Medical continues European expansion with first MINIject® surgeries in the Netherlands
December 22, 2023 07:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical continues European expansion with first MINIject® surgeries in the Netherlands WAVRE, Belgium — 22 December 2023: iSTAR Medical, a medtech company delivering...
iSTAR Medical conducts first MINIject® surgeries in Ireland, expanding commercial rollout in Europe
October 31, 2023 04:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical conducts first MINIject® surgeries in Ireland, expanding commercial rollout in Europe WAVRE, Belgium — 31 October 2023: iSTAR Medical, a medtech company...
iSTAR Medical presents positive three-year results for MINIject® from STAR-GLOBAL trial
September 07, 2023 03:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical presents positive three-year results for MINIject® from STAR-GLOBAL trial Interim three-year follow-up data further demonstrate consistent safety and efficacy of...
iSTAR Medical initiates international STAR-VI trial for the use of MINIject in conjunction with cataract surgery
March 15, 2023 07:00 ET
|
iSTAR Medical
MINIject® is the only commercially available MIGS implant targeting the supraciliary space Clinical data show positive, consistent results up to two-year follow-up in patients across Europe, Asia, and...
iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries in Sweden and Norway
December 01, 2022 03:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries in Sweden and Norway The only commercially available MIGS device currently targeting the supraciliary...
iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials
June 08, 2022 07:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...
iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials
June 08, 2022 02:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...
iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland
May 10, 2022 02:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland The only commercially available MIGS device currently targeting the supraciliary...
iSTAR Medical Continues Market Expansion with First MINIject® Surgeries in the UK
March 28, 2022 02:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical Continues Market Expansion with First MINIject® Surgeries in the UK UK patients and surgeons now able to benefit from the only commercially available MIGS device...